Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...